Rachael Walker

Enhancing Adoptive Cell Transfer with Combination BRAF-MEK and CDK4/6 Inhibitors in Melanoma

G. McArthur, C. Cullinane, K. Sheppard, 2021, Cancers.

A novel immunogenic mouse model of melanoma for the preclinical assessment of combination targeted and immune-based therapy

F. Souza-Fonseca-Guimaraes, G. McArthur, J. Oliaro, 2019, Scientific Reports.

Stage-dependent therapeutic efficacy in PI3K/mTOR-driven squamous cell carcinoma of the skin

R. Pearson, S. Jane, S. Dworkin, 2017, Cell Death & Differentiation.

Palbociclib synergizes with BRAF and MEK inhibitors in treatment naïve melanoma but not after the development of BRAF inhibitor resistance

R. Pearson, G. McArthur, R. Hannan, 2018, International journal of cancer.

Stage-dependent therapeutic efficacy in PI3K/mTOR-driven squamous cell carcinoma of the skin

R. Pearson, S. Jane, S. Dworkin, 2018, Cell Death & Differentiation.

Abstract 1716: Anticancer activity of the taxane nanoparticles, DEP®docetaxel and DEP®cabazitaxel

D. Owen, B. Kelly, Victoria M Mcleod, 2020, Clinical Research (Excluding Clinical Trials).